Basilea Pharmaceutica’s CHF 45.75 Million Shares Offering

Baker McKenzie advised Basilea Pharmaceutica Ltd. on all legal aspects of this PIPE transaction. Homburger advised the managers.Basilea Pharmaceutica Ltd. successfully completed a capital increase from authorized…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now